Understanding factors that limit the productivity of suspension-based perfusion cultures operated at high medium renewal rates.

One of the key parameters in perfusion culture is the rate of medium replacement (D). Intensifying D results in enhanced provision of nutrients, which can lead to an increase in the viable cell density (X(v)). The daily MAb production of hybridoma cells can thus be increased proportionally without modifying the bioreactor scale, provided that both viable cell yield per perfusion rate (Y(Xv/D)) and specific MAb productivity (q(MAb)) remain constant at higher D. To identify factors prone to limit productivity in perfusion, a detailed kinetic analysis was carried out on a series of cultures operated within a D range of 0.48/4.34 vvd (volumes of medium/reactor volume/day) in two different suspension-based systems. In the Celligen/vortex-flow filter system, significant reductions in Y(Xv/D) and q(MAb) resulting from the use of gas sparging were observed at D > 1.57 vvd (X(v) > 15 x 10(6) cells/mL). Through glucose supplementation, we have shown that the decrease in Y(Xv/D) encountered in presence of sparging was not resulting from increased cellular destruction or reduced cell growth, but rather from glucose limitation. Thus, increases in hydrodynamic shear stress imparted to the culture via intensification of gas sparging resulted in a gradual increase in specific glucose consumption (q(glc)) and lactate production rates (q(lac)), while no variations were observed in glutamine-consumption rates. As a result, while glutamine was the sole limiting-nutrient under non-sparging conditions, both glutamine and glucose became limiting under sparging conditions. Although a reduction in q(MAb) was observed at high-sparging rates, inhibition of MAb synthesis did not result from direct impact of bubbles, but was rather associated with elevated lactate levels (25-30 mM), resulting from shear stress-induced increases in q(lac), q(glc), and Y(lac/glc). Deleterious effects of sparging on Y(Xv/D) and q(MAb) encountered in the Celligen/vortex-flow filter system were eliminated in the sparging-free low-shear environment of the Chemap-HRI/ultrasonic filter system, allowing for the maintenance of up to 37 x 10(6) viable cells/mL. A strategy aimed at reducing requirements for sparging in large-scale perfusion cultures by way of a reduction in the oxygen demand using cellular engineering is discussed.

[1]  W. S. Hu,et al.  Use of surface aerator improve oxygen transfer in cell culture. , 1986, Biotechnology and bioengineering.

[2]  W. Burger,et al.  A Novel Ultrasonic Resonance Field Device for the Retention of Animal Cells , 1994, Biotechnology progress.

[3]  R Tom,et al.  On‐line monitoring of respiration in recombinant‐baculovirus infected and uninfected insect cell bioreactor cultures , 1996, Biotechnology and bioengineering.

[4]  Amanda G Paulovich,et al.  When Checkpoints Fail , 1997, Cell.

[5]  M. Takagi,et al.  An oxygen supply strategy for the large-scale production of tissue plasminogen activator by microcarrier cell culture , 1994 .

[6]  J. Côté,et al.  High-performance gel permeation chromatographic analysis of immunoglobulin M produced by hybridoma cell culture , 1992 .

[7]  D S Kompala,et al.  Inclined Sedimentation for Selective Retention of Viable Hybridomas in a Continuous Suspension Bioreactor , 1990, Biotechnology progress.

[8]  R. Lemieux,et al.  Characterization of higher avidity monoclonal antibodies produced by murine B-cell hybridoma variants selected for increased antigen binding of membrane Ig. , 1988, Journal of immunology.

[9]  F. Kargı,et al.  Biological responses of hybridoma cells to hydrodynamic shear in an agitated bioreactor. , 1991, Enzyme and microbial technology.

[10]  M Al-Rubeai,et al.  In hybridoma cultures, deprivation of any single amino acid leads to apoptotic death, which is suppressed by the expression of the bcl-2 gene. , 1998, Biotechnology and bioengineering.

[11]  J R Birch,et al.  Suspension culture of mammalian cells. , 1990, Bioprocess technology.

[12]  C. Chavarie,et al.  Improvement of recombinant protein production with the human adenovirus/293S expression system using fed-batch strategies. , 2000, Biotechnology and bioengineering.

[13]  M. Al‐Rubeai,et al.  Cell death in bioreactors: A role for apoptosis , 1994, Biotechnology and bioengineering.

[14]  J H Luong,et al.  Monitoring glutamine in mammalian cell cultures using an amperometric biosensor. , 1992, Biosensors & bioelectronics.

[15]  S. Mercille,et al.  Apoptosis-resistant E1B-19K-expressing NS/0 myeloma cells exhibit increased viability and chimeric antibody productivity under perfusion culture conditions. , 1999, Biotechnology and bioengineering.

[16]  H. Blanch,et al.  Cell retention–chemostat studies of hybridoma cells—analysis of hybridoma growth and metabolism in continuous suspension culture in serum‐free medium , 1993, Biotechnology and bioengineering.

[17]  B. Palsson,et al.  Effect of initial cell density on hybridoma growth, metabolism, and monoclonal antibody production. , 1990, Journal of biotechnology.

[18]  M. Butler,et al.  Nutritional aspects of the growth of animal cells in culture , 1989 .

[19]  D D Ryu,et al.  Monoclonal antibody productivity and the metabolic pattern of perfusion cultures under varying oxygen tensions , 1993, Biotechnology and bioengineering.

[20]  R. Mutharasan,et al.  Cell cycle‐ and growth phase‐dependent variations in size distribution, antibody productivity, and oxygen demand in hybridoma cultures , 1990, Biotechnology and bioengineering.

[21]  J. Auniņš,et al.  Large-scale mammalian cell culture. , 1997, Current opinion in biotechnology.

[22]  R. Gentz,et al.  High-density perfusion culture of insect cells with a biosep ultrasonic filter. , 1998, Biotechnology and bioengineering.

[23]  C. Gervais,et al.  Dose-dependent reduction of apoptosis in nutrient-limited cultures of NS/0 myeloma cells transfected with the E1B-19K adenoviral gene. , 1999, Biotechnology and bioengineering.

[24]  D F Ollis,et al.  Cell cycle model for antibody production kinetics. , 1989, Biotechnology and bioengineering.

[25]  C. Chavarie,et al.  Culture of insect cells in helical ribbon impeller bioreactor , 1991, Biotechnology and bioengineering.

[26]  C. Chavarie,et al.  Development of a helical‐ribbon impeller bioreactor for high‐density plant cell suspension culture , 1992, Biotechnology and bioengineering.

[27]  R. Lemieux,et al.  Hybridoma perfusion systems: A comparison study , 1992, Biotechnology and bioengineering.

[28]  A. Zeng,et al.  Variation of Stoichiometric Ratios and Their Correlation for Monitoring and Control of Animal Cell Cultures , 1998, Biotechnology progress.

[29]  W M Miller,et al.  Effects of elevated pCO(2) and/or osmolality on the growth and recombinant tPA production of CHO cells. , 1996, Biotechnology and bioengineering.

[30]  V. Dixit,et al.  Type I Insulin-like Growth Factor Receptor Activation Regulates Apoptotic Proteins* , 1996, The Journal of Biological Chemistry.

[31]  D. Robinson,et al.  Kinetics of recombinant immunoglobulin production by mammalian cells in continuous culture , 1991, Biotechnology and bioengineering.

[32]  J. Engasser,et al.  Influence of the culture oxygenation on the release of LDH by hybridoma cells , 1990 .

[33]  F. Duranti,et al.  Intracellular ionic variations in the apoptotic death of L cells by inhibitors of cell cycle progression. , 1995, Experimental cell research.

[34]  Amine Kamen,et al.  Design parameters and performance of a surface baffled helical ribbon impeller bioreactor for the culture of shear sensitive cells , 1992 .

[35]  N. Wang,et al.  Oxygen Mass Transfer Enhancement via Fermentor Headspace Pressurization , 1992, Biotechnology progress.

[36]  Daniel I. C. Wang,et al.  Effects of paddle impeller geometry on power input and mass transfer in small‐scale animal cell culture vessels , 1989, Biotechnology and bioengineering.

[37]  E. Feldman,et al.  Insulin‐like growth factor I rescues SH‐SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death , 1996, Journal of cellular physiology.

[38]  R. Lemieux,et al.  Filtration‐based perfusion of hybridoma cultures in protein‐free medium: Reduction of membrane fouling by medium supplementation with DNase I , 1994, Biotechnology and bioengineering.

[39]  S. Mercille,et al.  Induction of apoptosis in nutrient‐deprived cultures of hybridoma and myeloma cells , 1994, Biotechnology and bioengineering.

[40]  J. Ljunggren,et al.  Physiology of cultured animal cells. , 1997, Journal of biotechnology.

[41]  M. W. Weatherburn Phenol-hypochlorite reaction for determination of ammonia , 1967 .

[42]  S. Reuveny,et al.  Factors affecting cell growth and monoclonal antibody production in stirred reactors. , 1986, Journal of immunological methods.

[43]  H. Blanch,et al.  Continuous hybridoma suspension cultures with and without cell retention: kinetics of growth, metabolism and product formation. , 1992, Journal of biotechnology.

[44]  J. Wu Mechanisms of animal cell damage associated with gas bubbles and cell protection by medium additives. , 1995, Journal of biotechnology.

[45]  Martin Fussenegger,et al.  Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese hamster ovary cells , 1998, Nature Biotechnology.

[46]  W. Coakley,et al.  Enhanced sedimentation of mammalian cells following acoustic aggregation. , 1989, Biotechnology and bioengineering.

[47]  R. Lemieux,et al.  Long‐term perfusion culture of hybridoma: A “grow or die” cell cycle system , 1991, Biotechnology and bioengineering.

[48]  M. Butler,et al.  Glucose and glutamine metabolism of a murine B-lymphocyte hybridoma grown in batch culture , 1993, Applied biochemistry and biotechnology.

[49]  A. Lehninger Principles of Biochemistry , 1984 .

[50]  M. Silberklang,et al.  Optimization of a Fed‐batch Process for Production of a Recombinant Antibody , 1994, Annals of the New York Academy of Sciences.

[51]  A A Kamen,et al.  Use of the Centritech Lab Centrifuge for Perfusion Culture of Hybridoma Cells in Protein‐Free Medium , 1996, Biotechnology progress.

[52]  G. Banik,et al.  An investigation of cell density effects on hybridoma metabolism in a homogeneous perfusion reactor , 1994 .

[53]  E. Papoutsakis,et al.  Increased agitation intensity increases CD13 receptor surface content and mRNA levels, and alters the metabolism of HL60 cells cultured in stirred tank bioreactors. , 1998, Biotechnology and bioengineering.

[54]  B. Buckland,et al.  Monoclonal Antibody Process Development Using Medium Concentrates , 1994, Biotechnology progress.

[55]  E. Papoutsakis,et al.  Fluid-mechanical damage of animal cells in bioreactors. , 1991, Trends in biotechnology.

[56]  P. Greenfield,et al.  Mechanical agitation of hybridoma suspension cultures: Metabolic effects of serum, pluronic F68, and albumin supplements , 1992, Biotechnology and bioengineering.

[57]  D D Ryu,et al.  Cell cycle kinetics and monoclonal antibody productivity of hybridoma cells during perfusion culture , 1994, Biotechnology and bioengineering.

[58]  A J Sinskey,et al.  Reduction of waste product excretion via nutrient control: Possible strategies for maximizing product and cell yields on serum in cultures of mammalian cells , 1986, Biotechnology and bioengineering.

[59]  M. Fussenegger,et al.  A novel cytostatic process enhances the productivity of Chinese hamster ovary cells. , 1997, Biotechnology and bioengineering.

[60]  E. Papoutsakis,et al.  Media additives for protecting freely suspended animal cells against agitation and aeration damage. , 1991, Trends in biotechnology.

[61]  Wei-Shou Hu,et al.  Kinetics of Growth and Antibody Production by a Hybridoma Cell Line in a Perfusion Culture , 1990 .

[62]  James M. Piret,et al.  Acoustic Cell Filter for High Density Perfusion Culture of Hybridoma Cells , 1994, Bio/Technology.

[63]  C A Heath,et al.  Partial and Total Cell Retention in a Filtration‐Based Homogeneous Perfusion Reactor , 1995, Biotechnology progress.